Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1982 May;42(2):734–741. doi: 10.1128/jvi.42.2.734-741.1982

Analysis of vaccinia virus transcriptional complexity in vitro and in vivo: characterization of RNase T1-resistant 5'-terminal oligonucleotides.

C Whitkop, B R Lipinskas, S Mercer, D Panicali, E Paoletti
PMCID: PMC256900  PMID: 6806483

Abstract

Vaccinia virus mRNAs synthesized in vitro and in vivo, polyadenylated leader sequences synthesized in vitro in the absence of added GTP, CTP, or UTP or in the presence of 20 micrograms of actinomycin D per ml, and high-molecular-weight RNA synthesized in vitro under limiting ATP concentrations were labeled specifically in the cap structure using [alpha-32P]GTP and vaccinia-soluble enzyme extracts. The complexity of RNase T1-resistant 5'-terminal oligonucleotides was analyzed by two-dimensional polyacrylamide gel electrophoresis. Approximately 190 unique T1-resistant 5'-terminal oligonucleotides were observed from vaccinia virus 8 to 12S RNA synthesized in vitro. A somewhat greater complexity was observed with polyadenylated leader sequences and actinomycin D RNAs where unique T1-resistant oligonucleotides ranged from approximately 210 to 280 5'-terminal fragments. On a composite fingerprint of the above RNAs, more than 300 identifiable unique T1-resistant 5'-terminal oligonucleotides were observed. Significantly, close to 300 T1-resistant fragments were derived from RNA sedimenting faster than 18S on denaturing sucrose gradients. Analysis of vaccinia RNAs synthesized in vivo in the absence of either de novo protein synthesis or DNA replication or in the presence of actinomycin D gave essentially similar profiles of 5'-terminal T1-resistant oligonucleotide fingerprints consisting of approximately 200 fragments. Analysis of the 5'-terminal T1-resistant oligonucleotides of vaccinia RNAs present after DNA replication showed essentially the same pattern of early T1-fragments albeit in reduced amounts but in addition revealed a complex pattern of T1-resistant oligonucleotides unique to this class of vaccinia RNA.

Full text

PDF
734

Images in this article

736Image
on p.736
737Image
on p.737
738Image
on p.738

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker C. C., Herisse J., Courtois G., Galibert F., Ziff E. Messenger RNA for the Ad2 DNA binding protein: DNA sequences encoding the first leader and heterogenity at the mRNA 5' end. Cell. 1979 Oct;18(2):569–580. doi: 10.1016/0092-8674(79)90073-4. [DOI] [PubMed] [Google Scholar]
  2. Boone R. F., Moss B. Methylated 5'-terminal sequences of vaccinia virus mRNA species made in vivo at early and late times after infection. Virology. 1977 Jun 1;79(1):67–80. doi: 10.1016/0042-6822(77)90335-x. [DOI] [PubMed] [Google Scholar]
  3. Boone R. F., Moss B. Sequence complexity and relative abundance of vaccinia virus mRNA's synthesized in vivo and in vitro. J Virol. 1978 Jun;26(3):554–569. doi: 10.1128/jvi.26.3.554-569.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bossart W., Paoletti E., Nuss D. L. Cell-free translation of purified virion-associated high-molecular-weight RNA synthesized in vitro by vaccinia virus. J Virol. 1978 Dec;28(3):905–916. doi: 10.1128/jvi.28.3.905-916.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Canaani D., Kahana C., Mukamel A., Groner Y. Sequence heterogeneity at the 5' termini of late simian virus 40 19S and 16S mRNAs. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3078–3082. doi: 10.1073/pnas.76.7.3078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cooper J. A., Moss B. In vitro translation of immediate early, early, and late classes of RNA from vaccinia virus-infected cells. Virology. 1979 Jul 30;96(2):368–380. doi: 10.1016/0042-6822(79)90095-3. [DOI] [PubMed] [Google Scholar]
  7. Denhardt D. T. A membrane-filter technique for the detection of complementary DNA. Biochem Biophys Res Commun. 1966 Jun 13;23(5):641–646. doi: 10.1016/0006-291x(66)90447-5. [DOI] [PubMed] [Google Scholar]
  8. Flavell A. J., Cowie A., Arrand J. R., Kamen R. Localization of three major cappe 5' ends of polyoma virus late mRNA's within a single tetranucleotide sequence in the viral genome. J Virol. 1980 Feb;33(2):902–908. doi: 10.1128/jvi.33.2.902-908.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Flavell A. J., Cowie A., Legon S., Kamen R. Multiple 5' terminal cap structures in late polyoma virus RNA. Cell. 1979 Feb;16(2):357–371. doi: 10.1016/0092-8674(79)90012-6. [DOI] [PubMed] [Google Scholar]
  10. Gershowitz A., Boone R. F., Moss B. Multiple roles for ATP in the synthesis and processing of mRNA by vaccinia virus: specific inhibitory effects of adenosine (beta,gamma-imido) triphosphate. J Virol. 1978 Aug;27(2):399–408. doi: 10.1128/jvi.27.2.399-408.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gershowitz A., Moss B. Abortive transcription products of vaccinia virus are guanylylated, methylated, and polyadenylylated. J Virol. 1979 Sep;31(3):849–853. doi: 10.1128/jvi.31.3.849-853.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ghosh P. K., Reddy V. B., Swinscoe J., Lebowitz P., Weissman S. M. Heterogeneity and 5'-terminal structures of the late RNAs of simian virus 40. J Mol Biol. 1978 Dec 25;126(4):813–846. doi: 10.1016/0022-2836(78)90022-0. [DOI] [PubMed] [Google Scholar]
  13. Glisin V., Crkvenjakov R., Byus C. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry. 1974 Jun 4;13(12):2633–2637. doi: 10.1021/bi00709a025. [DOI] [PubMed] [Google Scholar]
  14. Haegeman G., Fiers W. Characterization of the 5'-terminal cap structures of early simian virus 40 mRNA. J Virol. 1980 Sep;35(3):955–961. doi: 10.1128/jvi.35.3.955-961.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Harper J. M., Parsonage M. T., Pelham H. R., Darby G. Heat inactivation of vaccinia virus particle-associated functions: properties of heated particles in vivo and in vitro. J Virol. 1978 Jun;26(3):646–659. doi: 10.1128/jvi.26.3.646-659.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. JOKLIK W. K. The preparation and characteristics of highly purified radioactively labelled poxvirus. Biochim Biophys Acta. 1962 Aug 20;61:290–301. doi: 10.1016/0926-6550(62)90091-9. [DOI] [PubMed] [Google Scholar]
  17. Kates J. R., McAuslan B. R. Poxvirus DNA-dependent RNA polymerase. Proc Natl Acad Sci U S A. 1967 Jul;58(1):134–141. doi: 10.1073/pnas.58.1.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kaverin N. V., Varich N. L., Surgay V. V., Chernos V. I. A quantitative estimation of poxvirus genome fraction transcribed as "early" and "late" mRNA. Virology. 1975 May;65(1):112–119. doi: 10.1016/0042-6822(75)90011-2. [DOI] [PubMed] [Google Scholar]
  19. Moss B. Utilization of the guanylyltransferase and methyltransferases of vaccinia virus to modify and identify the 5'-terminals of heterologous RNA species. Biochem Biophys Res Commun. 1977 Jan 24;74(2):374–383. doi: 10.1016/0006-291x(77)90314-x. [DOI] [PubMed] [Google Scholar]
  20. Munyon W., Paoletti E., Grace J. T., Jr RNA polymerase activity in purified infectious vaccinia virus. Proc Natl Acad Sci U S A. 1967 Dec;58(6):2280–2287. doi: 10.1073/pnas.58.6.2280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nuss D. L., Paoletti E. Methyl group analysis of virion-associated high-molecular-weight RNA synthesized in vitro by purified vaccinia virus. J Virol. 1977 Jul;23(1):110–116. doi: 10.1128/jvi.23.1.110-116.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Oda K. I., Joklik W. K. Hybridization and sedimentation studies on "early" and "late" vaccinia messenger RNA. J Mol Biol. 1967 Aug 14;27(3):395–419. doi: 10.1016/0022-2836(67)90047-2. [DOI] [PubMed] [Google Scholar]
  23. Paoletti E., Grady L. J. Transcriptional complexity of vaccinia virus in vivo and in vitro. J Virol. 1977 Sep;23(3):608–615. doi: 10.1128/jvi.23.3.608-615.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Paoletti E. High molecular weight virion-associated RNA of vaccinia. A possible precursor to 8 to 12 S mRNA. J Biol Chem. 1977 Feb 10;252(3):872–877. [PubMed] [Google Scholar]
  25. Paoletti E. In vitro synthesis of a high molecular weight virion-associated RNA by vaccinia. J Biol Chem. 1977 Feb 10;252(3):866–871. [PubMed] [Google Scholar]
  26. Paoletti E., Lipinskas B. R., Panicali D. Capped and polyadenylated low-molecular-weight RNA synthesized by vaccinia virus in vitro. J Virol. 1980 Jan;33(1):208–219. doi: 10.1128/jvi.33.1.208-219.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Paoletti E., Lipinskas B. R. Soluble endoribonuclease activity from vaccinia virus: specific cleavage of virion-associated high-molecular-weight RNA. J Virol. 1978 Jun;26(3):822–824. doi: 10.1128/jvi.26.3.822-824.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Paoletti E., Lipinskas B. R. The role of ATP in the biogenesis of vaccinia virus mRNA in vitro. Virology. 1978 Jun 15;87(2):317–325. doi: 10.1016/0042-6822(78)90137-x. [DOI] [PubMed] [Google Scholar]
  29. Spencer E., Loring D., Hurwitz J., Monroy G. Enzymatic conversion of 5'-phosphate-terminated RNA to 5'-di- and triphosphate-terminated RNA. Proc Natl Acad Sci U S A. 1978 Oct;75(10):4793–4797. doi: 10.1073/pnas.75.10.4793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Varich N. L., Sychova I. V., Kaverin N. V., Antonova T. P., Chernos V. I. Transcription of both DNA strands of vaccinia virus genome in vivo. Virology. 1979 Jul 30;96(2):412–430. doi: 10.1016/0042-6822(79)90099-0. [DOI] [PubMed] [Google Scholar]
  31. Wahl G. M., Stern M., Stark G. R. Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate. Proc Natl Acad Sci U S A. 1979 Aug;76(8):3683–3687. doi: 10.1073/pnas.76.8.3683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wei C. M., Moss B. Methylated nucleotides block 5'-terminus of vaccinia virus messenger RNA. Proc Natl Acad Sci U S A. 1975 Jan;72(1):318–322. doi: 10.1073/pnas.72.1.318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wittek R., Cooper J. A., Barbosa E., Moss B. Expression of the vaccinia virus genome: analysis and mapping of mRNAs encoded within the inverted terminal repetition. Cell. 1980 Sep;21(2):487–493. doi: 10.1016/0092-8674(80)90485-7. [DOI] [PubMed] [Google Scholar]
  34. de Wachter R., Fiers W. Preparative two-dimensional polyacrylamide gel electrophoresis of 32 P-labeled RNA. Anal Biochem. 1972 Sep;49(1):184–197. doi: 10.1016/0003-2697(72)90257-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES